Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Czech Republic
Summary - Medicinal Products Containing Risankizumab, Tofacitinib, Aprremilast, Mirikizumab, Deukravacitinib, Voclosporin, Siltuximab
Deadline - Apr 15, 2025
GT reference number - 105152815
Product classification - Immunosuppressive agents
Address - Czech Republic
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 105152815
Document Type - Tender Notices
Description - Description: The subject of the public contract is continuous supplies of medicinal products containing risankizumab, tofacitinib, Aprremilast, mirikizumab, deukravacitinib, voclosporin, siltuximab for 4 years according to the current needs of the cl ient.local title:: Léčivé přípravky s obsahem risankizumabu, tofacitinibu, apremilastu, mirikizumabu, deukravacitinibu, voklosporinu, siltuximabuContract Duration: : 4 YEARContract Type: : Supplylocal description: : Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem risankizumabu, tofacitinibu, apremilastu, mirikizumabu, deukravacitinibu, voklosporinu, siltuximabu po dobu 4 let dle aktuálních potř
Gt Ref Id - 105152815
Deadline - Apr 15, 2025
Similar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
